LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.
LenioBio has raised €16M across 3 funding rounds from 3 investors, most recently a Grant round in Jul 2025. Based in Dusseldorf, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-07-28 | Grant | €3.7M | European Health and Digital Executive Agency (HaDEA) | View deal → |
| 2023-09-14 | Grant | €900k | EIT Food | View deal → |
| 2022-03-08 | Series A | €12M | Bridford Group | View deal → |
